Identification of three new HLA-DQB1 alleles: HLA-DQB1*03:02:33, -DQB1*04:79 and -DQB1*05:249.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
04 2021
Historique:
revised: 19 11 2020
received: 16 11 2020
accepted: 20 11 2020
pubmed: 27 11 2020
medline: 8 7 2021
entrez: 26 11 2020
Statut: ppublish

Résumé

Three new DQB1*03:02:33, DQB1*04:79 and DQB1*05:249 alleles detected in Russian individuals by next-generation sequencing.

Identifiants

pubmed: 33241914
doi: 10.1111/tan.14149
doi:

Substances chimiques

HLA-DQ beta-Chains 0
HLA-DQB1 antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-380

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Marsh SGE. Nomenclature for factors of the HLA system, update April, ay and June 2020. HLA. 2020;96:384-412.
Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D455.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Anastasiia Ananeva (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Nailia Osipova (N)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Alina Shaihutdinova (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Anna Andryushkina (A)

National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation.

Elena Shagimardanova (E)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH